AVROBIO Alternatives & Competitors
12 companies similar to AVROBIO — Clinical-stage lentiviral gene therapy company, powered by plato®. Our vision: b...
Companies similar to AVROBIO
Orchard Therapeutics - U.S.
Dedicated to transforming the lives of patients with severe and other genetic diseases thr...
London, United Kingdom
Genenta Science (Nasdaq: GNTA)
Genenta is a clinical stage immuno-oncology company
Milan, Italy
Altheia Science
Altheia Science develops treatments for autoimmune diseases and cancer using innovative to...
Milano, Italy
Jasper Therapeutics
Jasper is a biotechnology company focused on targeting mast cells and stem cells to treat...
Redwood City, United Stat...
Rival Readout
Competing with AVROBIO? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Appia Bio
Collaborates across a diversity of disciplines, which is critical to developing next-gener...
bluebird bio
Pursuing curative gene therapies to give patients and their families more bluebird days.
Somerville, United States
Angiocrine Bioscience, Inc.
Transforming medicine through engineered cellular therapies that restore, regenerate, and...
San Diego, United States
AlveoGene
Transforming Rare Respiratory Disease Outcomes Using Inhaled Genes Therapy
American Gene Technologies® International Inc.
Our mission is to leverage the power of gene and cell therapy to reduce human suffering fr...
Rockville, United States
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Spur Therapeutics
Toward the next generation of gene therapy.
Stevenage, United Kingdom
Celularity Inc.
A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectiou...
United States
About AVROBIO
AVROBIO is a United States-based, clinical-stage biotechnology company founded in 2015. With its headquarters in Cambridge, Mass., the firm is advancing the field of gene therapy with its proprietary plato® platform. Driven by the slogan, "Clinical-stage lentiviral gene therapy company, powered by plato®.
Gene Therapy, Lentiviral Gene Therapy, Clinical Stage, Plato Platform, Personalized Medicine, Genetic Disease, Hematopoietic Stem Cells, Gaucher Disease, Hunter Syndrome, Pompe Disease, Cambridge, Clinical Programs, Global Commercialization
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around AVROBIO: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at AVROBIO on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
